Farm DME o & m support

Ended Awarded Last action

Contract number
75F40122F80214
Awardee
Awarding agency
Obligated
$4,563,608

Award facts

Contract value 95% obligated
  • $4,563,607.97 Current, with exercised options
  • $4,818,936.45 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
8(a) Sole Source
Competition
Full and Open Competition after exclusion of sources · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Savage, MD 20763, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Change Order P00004 $0
Exercise an Option P00003 $373,312
Exercise an Option P00002 $1,523,061
Exercise an Option P00001 $1,353,685
Original award $1,313,550

About this award

The Food and Drug Administration (FDA) awarded a delivery order to Versatech Inc., a minority-owned small disadvantaged business based in Savage, Maryland, for Farm Demonstration Medical Equipment Operations and Maintenance support. Issued on July 6, 2022, this 8(a) sole source contract carries a ceiling value of $4.8 million and is scheduled for completion by October 10, 2025. The work will be performed at Versatech's facility in Savage, Maryland, and is funded through the FDA's broader IT and mission support initiatives. This delivery order falls under the Chief Information Officer - Solutions and Partners 3, Small Business (CIO-SP3 SB) Government-Wide Acquisition Contract (GWAC), which provides federal agencies with comprehensive information technology and telecommunications services.

Versatech brings substantial relevant experience to this engagement, having established a proven track record serving the FDA across multiple contract vehicles since 2007. The company specializes in audio visual integration, IT system maintenance, cybersecurity services, and mission-critical support across various FDA centers, including the Center for Drug Evaluation and Research and the Center for Food Safety and Applied Nutrition. The 8(a) sole source set-aside designation reflects the FDA's confidence in Versatech's capabilities to deliver specialized operations and maintenance support for the agency's demonstration medical equipment initiatives. This contract represents a continuation of Versatech's established relationship with the FDA, leveraging the company's technical expertise and understanding of the agency's complex operational requirements.

Quick answers

Who was awarded contract 75F40122F80214?

75F40122F80214 was awarded to Versatech Inc. by Food and Drug Administration (Department of Health and Human Services) on July 6, 2022.

How much is contract 75F40122F80214 worth?

The government has obligated $4,563,608 on 75F40122F80214. Its potential value, with all options, is $4,818,936.

Is contract 75F40122F80214 an order under another contract?

Yes. 75F40122F80214 is a delivery order under 75N98119D00077, a government wide acquisition contract (GWAC), on Chief Information Officer - Solutions and Partners 3, Small Business (CIO-SP3 SB).

Was contract 75F40122F80214 competed?

The extent of competition for 75F40122F80214 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: 8(a) Sole Source.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award